(5619) Stock Price

Marso operates a healthcare platform business that connects medical facilities with individuals, corporations, and government agencies, with a focus on preventive medicine. The company is digitizing analog operations and provides "MRSO.jp," a search and reservation website for health checkups and medical examinations, and "MRS," a web reservation system for medical facilities, as its core services.

Key customers include patients (individuals), medical facilities ranging from national and public hospitals to clinics, life insurance companies, corporations, and local governments. The company's revenue is primarily based on performance fees received from medical facilities according to the consultation amount when actual visits occur through reservations. Advertising generates stable income through fixed monthly fees, while DX services and offerings for corporations and municipalities are based on fixed monthly fees. This diversified model ensures stable revenue streams.

The business is organized into four segments: "Reservations," "Advertising," "DX," and "Vaccines." In the reservations segment, the company prioritizes expanding the number of listed facilities and reservation transaction volume. In DX, the company offers various options centered on MRSO-Plus to support everything from reservations to health examination result management, and aims to expand fixed-fee revenue through health checkup management services for corporations and municipalities. Vaccine-related demand has contracted due to changes in government policy, so the company is concentrating management resources on growth areas: reservations, DX, and advertising.

The company aims to realize "8 additional years of healthy life (+8Y)" centered on preventive medicine. As a growth strategy, the company plans to expand market share in the 2023 human dock and health screening market (approximately 944 billion yen) by promoting web-based reservations and digital transformation (DX), with revenue and operating profit as key management indicators. Specific KPIs include reservation transaction volume through MRSO.jp and MRS, the number of listed medical facilities and members, and contract account numbers for medical facilities, corporations, and government agencies, with business value measured by growth in these metrics.

The company prioritizes investment in reservation platforms and DX services for medical facilities. Through search and reservation functionality via MRSO.jp, the web-based reservation system "MRS" for medical institutions, and expanded features such as MRSO-Plus—which supports everything from reservations to health screening result management—the company promotes digitalization away from traditional phone and fax-based operations. As a differentiation strategy, leveraging capital and business partnerships with major health screening agencies, the company builds a "Business Healthcare Platform" that provides integrated services connecting companies, health insurance organizations, and medical facilities to support corporate health screenings on a one-stop basis.

For new market development, the company strengthens sales efforts in statutory health screening and corporate and health insurance organization segments. Focusing on group clients such as companies and health insurers—which represent approximately 60% of the market—the company pursues expansion of corporate reservations through joint projects with health screening agencies. Going forward, the company will conduct continuous outreach to approximately 4,500 medical facilities, expanding listing slots and statutory health screening reservation capacity while promoting adoption among local governments, aiming for sustained growth in reservation transaction volume and expanded recurring revenue.

In technological innovation, the company prioritizes stable service operations and enhanced security, obtaining and renewing ISMS, QMS, and privacy mark certifications. On the systems side, the company advances cloud service robustness, operational improvements through PDCA cycles, and sophisticated performance management through data utilization, while strengthening development capabilities through overseas subsidiary management and engineer recruitment and training. Through these investments, the company aims to improve operational efficiency for medical facilities and user convenience, establishing a leading position in the healthcare sector.